Funding Received
$73 Million in 3 Rounds from 4 Investors
Most Recent Funding
$41 Million Series B on April 7, 2014
Founded:
2006
Headquarters:
South San Francisco, CA
Description:
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Founders:
John Donovan, Leonid Beigelman, Lawrence Blatt
Categories:
Biotechnology
Website:
http://www.aliosbiopharma.com

Detailed Description

Update

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

Current Team (3)

Update

Board Members and Advisors (19)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Business Address

    260 East Grand Ave,

    2nd Floor

    South San Francisco, CA 94080

    USA

Images (2)

Update
  • N0klooyvjbnrbxcofiwz
  • 63c4976a4a765845ff26b9d2741941ae